Share on LinkedInShare on LinkedIn

ARTICLE · 08 JULY 2021

CN Supreme Court's Stipulations On Patent Linkage Related Trials

These stipulations were announced by the CN Supreme People's Court on 5 July 2021, one day after the announcement of the NMPA's measures. The announcement is as below...

ChinaIntellectual Property

This is related to my earlier article below:

https://www.linkedin.com/pulse/cn-patent-inkage-measures-trial-finalized-issued-nmpa-toby-mak/?trackingId=UtK3oBGzQpe%2FL%2BFSPHB1tQ%3D%3D

These stipulations were announced by the CN Supreme People's Court on 5 July 2021, one day after the announcement of the NMPA's measures. The announcement is as below:

http://www.court.gov.cn/fabu-xiangqing-311791.html

My observations are as below:

  • Again, there is NO 9-month deadline to conclude a trial at a court (the Beijing IP Court, more specifically, which is named in the stipulations to be the court to handle such patent linkage cases, Article 1). It should also note that there is no provision in these stipulations to put such trials at high priority, specifically to be concluded more quickly. Whether this would make the patent linkage system toothless in China (if many of such cases could be delayed by the generic drug applicant to be decided beyond the 9-month

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from